MedTrace Logo

MDR - Longevity IT Oblique and Offset Liners

NCT05980234 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-12-27

No results posted yet for this study

Summary

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumentation) at a minimum of 10-year follow-up.

Conditions

  • Non-inflammatory Degenerative Joint Disease (NIDJD)
  • Avascular Necrosis
  • Protrusio Acetabuli
  • Traumatic Arthritis
  • Slipped Capital Femoral Epiphyses
  • Fracture of the Pelvis
  • Diastrophic Variant
  • Osteoarthritis
  • Fused Hip

Interventions

DEVICE

Total Hip Arthroplasty with Longevity IT Oblique Liners

Primary or Revision Total Hip Arthroplasty using the Longevity IT Oblique liners according to the approved indications and compatible device.

DEVICE

Total Hip Arthroplasty with Longevity IT Offset Liners

Primary or Revision Total Hip Arthroplasty using the Longevity IT Offset liners according to the approved indications and compatible device.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hillary Overholser · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-30
Primary Completion
2024-11-02
Completion
2024-11-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05980234 on ClinicalTrials.gov